Pharmaceutical Promotion at Its Productivity Frontier

* Reuters is not responsible for the content in this press release.

Tue Jun 30, 2009 2:11pm EDT

Briefing Note from Blue Spoon Consulting Updated to Reflect IMS Health v. Ayotte
NEW YORK--(Business Wire)--
Blue Spoon Consulting Group, LLC, today published a briefing note that looks at
the interplay of market dynamics influencing the pharmaceutical, marketing
services, and data vendor industries. Available for download through the Blue
Spoon Consulting website (www.bluespoonconsulting.com), this is a systemic look
at structural change affecting pharmaceutical marketers, and integrates the
Supreme Court`s refusal to review New Hampshire`s data-mining law, IMS Health v.
Ayotte. By exploring the deeper and more fundamental forces shaping the contours
of the future, the briefing note provides context to craft strategy in an age of
transition. 

Blue Spoon is a leading strategy and marketing innovation consultancy serving
the global pharmaceutical industry. We are unique with an ability to create at a
system level, an approach that enables an evolutionary leap in solutions for
growth and competitive advantage. Visit: www.bluespoonconsulting.com. 



Blue Spoon Consulting
John Singer, 917-538-4239
john@bluespoonconsulting.com

Copyright Business Wire 2009

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.